
Elevance Health, Inc.
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. It also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, the company provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. It provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.
Analysis Summary
Key Highlights
- • The document is a legal disclosure, not an earnings call transcript.
- • No Q4 2025 financial results, guidance, or performance metrics are provided.
- • It references a press release for Q3 2025 financial results as an exhibit.
- • Contains extensive boilerplate language regarding forward-looking statements.
- • Includes a detailed list of general risk factors for the company and the healthcare industry.
- • Lacks management commentary, strategic updates, or analyst Q&A.
Financial Metrics
Stock Performance (90 Days)
Positive Signals
- • No specific positive indicators mentioned in this legal boilerplate.
Risks & Concerns
- — Trends in healthcare costs and utilization rates.
- — Impact of new or changes in existing federal, state, and international healthcare regulations.
- — Impact of cyber-attacks or other privacy/data security incidents.
- — Changes in economic and market conditions.
- — Risks and uncertainties regarding Medicare and Medicaid programs.
Full Transcript
Recent Elevance Health, Inc. News
Stock Price
Company Info
- Website
- www.elevancehealth.com
- Industry
- Healthcare Plans
- Sector
- Healthcare
- Headquarters
- Indianapolis, IN, United States
- CEO
- Ms. Gail Koziara Boudreaux
- Employees
- 104,200
Layoff Stats
- Layoff Events
- 0
- Total Affected
- 0
Recent Layoffs
No canonical layoff events recorded for this company.